Mild COVID-19 Despite End Stage Liver Disease

摘要

With over 12 million confirmed cases and worldwide mortality exceeding 550,000 persons, COVID19 infection has quickly become a global threat to public health1 . In patients with chronic liver disease, emerging reports suggest an increased risk of morbidity and mortality from COVID-19. Given the immunocompromised status of these patients and high rates of comorbidities, one might expect increased susceptibility to infection. Whether the disease course in these patients is more severe, with increased rate of complications and mortality has yet to be firmly established.